Pollen from multiple sunflower cultivars and species reduces a common bumblebee gut pathogen

Pathogens are one of the factors driving pollinator declines. Diet can play an important role in mediating pollinator health and resistance to pathogens. Sunflower pollen (Helianthus annuus) dramatically reduced a gut pathogen (Crithidia bombi) of Bombus impatiens previously, but the breadth of this effect was unknown. We tested whether pollen from nine H. annuus cultivars, four wild H. annuus populations, H. petiolarus, H. argophyllus and two Solidago spp., reduced Crithidia in B. impatiens compared to mixed wildflower pollen and buckwheat pollen (Fagopyrum esculentum) as controls. We also compared hand- and honeybee-collected pollen (which contains nectar) to assess whether diet effects on pathogens were due to pollen or nectar. All Helianthus and Solidago pollen reduced Crithidia by 20–40-fold compared to buckwheat pollen, and all but three taxa reduced Crithidia compared to wildflower pollen. We found no consistent differences between hand- and bee-collected pollen, suggesting that pollen alone can reduce Crithidia infection. Our results indicate an important role of pollen diet for bee health and potentially broad options within the Asteraceae for pollinator plantings to manage bee disease

Photocatalytic Aminodecarboxylation of Carboxylic Acids

Aminodecarboxylation of unactivated alkyl carboxylic acids has been accomplished utilizing an organic photocatalyst. This operationally simple reaction utilizes readily available carboxylic acids to chemoselectively generate reactive alkyl intermediates that are not accessible via conventional two-electron pathways. The organic radical intermediates are efficiently trapped with electrophilic diazo compounds to provide aminated alkanes.Division of Chemistry. Grant Number: 146517

Deglacial laminated facies on the NW European continental margin: The hydrographic significance of British-Irish Ice Sheet deglaciation and Fleuve Manche paleoriver discharges

[1] We have compiled results obtained from four high sedimentation rate hemipelagic sequences from the Celtic sector of the NW European margin ( NE Atlantic) to investigate the paleoceanographic and paleoclimatic evolution of the area over the last few climatic cycles. We focus on periods characteristic of deglacial transitions. We adopt a multiproxy sedimentological, geochemical, and micropaleontological approach, applying a sampling resolution down to ten microns for specific intervals. The investigation demonstrates the relationships between the Bay of Biscay hydrography and the glacial/deglacial history of both the proximal British-Irish Ice Sheet (BIIS) and the western European continent. We identify recurrent phases of laminae deposition concurrent with major BIIS deglacial episodes in all the studied cores. Evidence for abrupt freshwater discharges into the open ocean highlights the influence of such events at a regional scale. We discuss their impact at a global scale considering the present and past key location of the Bay of Biscay versus the Atlantic Meridional Overturning Circulation (AMOC)

New and improved proteomics technologies for understanding complex biological systems: Addressing a grand challenge in the life sciences

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/93688/1/pmic7183.pd

Serum heart-type fatty acid-binding protein and cerebrospinal fluid tau: Marker candidates for dementia with Lewy bodies

Background: The measurement of biomarkers in cerebrospinal fluid (CSF) has gained increasing acceptance in establishing the diagnosis of some neurodegenerative diseases. Heart-type fatty acid-binding protein (H-FABP) was recently discovered in CSF and serum of patients with neurodegenerative diseases. Objective: We investigated H-FABP in CSF and serum alone and in combination with CSF tau protein to evaluate these as potential biomarkers for the differentiation between dementia with Lewy bodies (DLB) and Alzheimer's disease (AD). Methods: We established H-FABP and tau protein values in a set of 144 persons with DLB (n = 33), Parkinson disease with dementia (PDD; n = 25), AD (n = 35) and nonclemented neurological controls (NNC; n = 51). Additionally, serum H-FABP levels were analyzed in idiopathic Parkinson disease patients without evidence of cognitive decline (n = 45) using commercially available enzyme-linked immunosorbent assays. We calculated absolute values of HFABP and tau protein in CSF and serum and established relative ratios between the two to obtain the best possible match for the clinical working diagnosis. Results: Serum HFABP levels were elevated in DLB and PDD patients compared with NNC and AD subjects. To better discriminate between DLB and AD, we calculated the ratio of serum H-FABP to CSF tau protein levels. At the arbitrary chosen cutoff ratio >= 8 this quotient reached a sensitivity of 91% and a specificity of 66%. Conclusion: Our results suggest that the measurement of CSF tau protein, together with H-FABP quantification in serum and CSF, and the ratio of serum H-FABP to CSF tau protein represent marker candidates for the differentiation between AD and DLB. Copyright (c) 2007 S. Karger AG, Basel